Patient P-01789

Synthetic patientNBL-101 · Day 118 · 25–34 · F · baseline S16Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Treatment adherence-7
GI instability-6
Inflammatory activity-4
Nutritional resilience+4
Toxicity+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

24.4/100

worsening · +9.1 vs previous 14 d

Toxicity

Blood

8.8/100

improving · -9.8 vs previous 14 d

Sleep quality

Wearable

64.7/100

stable · -1.2 vs previous 14 d

Energy level

Daily log

6.2/10

stable · +0.1 vs previous 14 d

Stress level

Daily log

3.4/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

3,185

worsening · -489 vs previous 14 d

Adherence

Companion

86.2 %

stable · +0.2 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 76 from the failing basin, 13 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Antibiotic course
perturbation · steering -4.7
Poor-sleep week
perturbation · steering -3
Low-HRV stretch
perturbation · steering -2.7

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
-2.4no signal · 44%
Histamine load
-1.9no signal · 37%
Dietary fat load
+1.5no signal · 28%
Insoluble fibre
-0.7no signal · 15%
Spicy / capsaicin
+0.5no signal · 15%
Simple carbohydrates
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↑20
- Wearable3,185 steps/day

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.3 · butyrate capacity 78/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 64 ms
Sleep: 6.9 h
Steps: 3,467
Resting HR: 72 bpm

Daily log: GI score 24, nutritional resilience 66, adherence 86.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01541	34%	S09	AD-05	no change	43
P-01804	34%	S19	AD-05	improved	61
P-01377	32%	S11	AD-05	no change	42
P-01483	30%	S14	AD-05	no change	35
P-01677	36%	S05	BR-03	no change	86
P-01329	35%	S08	BR-03	improved	79
P-01689	34%	S13	BR-03	no change	50
P-01468	30%	S06	BR-03	no change	41
P-01495	30%	S07	BR-03	improved	85
P-01430	34%	S05	CR-01	improved	54
P-01724	46%	S10	DT-01	improved	63
P-01767	41%	S14	DT-01	no change	63